Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Aignostics is an AI-powered company transforming drug development and improving patient outcomes through precision medicine. They offer a range of products including Foundation Models and the Atlas…

Aignostics is an AI-powered company transforming drug development and improving patient outcomes through precision medicine. They offer a range of products including Foundation Models and the Atlas…
Headquarters: Berlin, Germany (offices also in New York)
Founded: 2018 (spun out 2020)
Focus: Explainable AI for pathology — precision diagnostics, drug development, translational research
Latest round: Series B, $34M (Oct 29, 2024)
Total funding: ≈ $55M
ISO 13485 and 27001; GCP-ready clinical trial platform
Computational pathology and precision medicine for diagnostics and drug development
2018
Biotechnology
€14,000,000
Series A reported (~€14M)
$34,000,000
Series B announced Oct 29, 2024
“ATHOS led Series B; participation from Mayo Clinic, HTGF, Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund/Ascenion, IBB Ventures”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week
| Company |
|---|